ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,712.20
0.00%
US Tech 100
19,357.60
-0.09%
Dow Jones
42,454.79
0.00%
Brent Oil
73.065
-0.44%
Bitcoin
86,888.44
0.00%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Celyad Oncology SA (CYAD) Quote

Celyad Oncology SA

Celyad Oncology SA (CYAD)

EU
0.54
-0.028
( -4.93% )
Updated: 08:31:04
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
0.54
Bid
0.523
Ask
0.545
Volume
22,140
0.54 Day's Range 0.56
0.212 52 Week Range 1.22
Market Cap
22.372M
Previous Close
0.568
Open
0.56
Last Trade
53
@
0.54
Last Trade Time
08:02:46
Financial Volume
-
VWAP
-
Average Volume (3m)
75,066
Shares Outstanding
41,429,000
Dividend Yield
-
PE Ratio
-2.70
Earnings Per Share (EPS)
-0.2
Revenue
102k
Net Profit
-8.45M

About Celyad Oncology SA

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.celyad.com
Headquarters
Mont-saint-guibert, Walloon Brabant, Bel
Founded
-
Celyad Oncology SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker CYAD. The last closing price for Celyad Oncology was 0.57 €. Over the last year, Celyad Oncology shares have traded in a share price range of 0.212 € to 1.22 €.

Celyad Oncology currently has 41,429,000 shares outstanding. The market capitalization of Celyad Oncology is 23.53 € million. Celyad Oncology has a price to earnings ratio (PE ratio) of -2.70.

Ask ADVFN Intelligence (AI)

CYAD Latest News

More News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.096-15.09433962260.6360.6360.54276320.56093413DE
40.0071.313320825520.5330.650.45600500.54947569DE
12-0.144-21.05263157890.6840.9640.41750660.60790846DE
260.2715101.1173184360.26851.220.25824850.66294218DE
520.18552.11267605630.3551.220.212480970.60120987DE
156-1.56-74.28571428572.12.550.212414160.92896093DE
260-6.46-92.2857142857712.080.212423372.8468321DE

CYAD - Frequently Asked Questions (FAQ)

What is the current Celyad Oncology share price?
The current share price of Celyad Oncology is 0.54 €
How many Celyad Oncology shares are in issue?
Celyad Oncology has 41,429,000 shares in issue
What is the market cap of Celyad Oncology?
The market capitalisation of Celyad Oncology is EUR 23.53M
What is the 1 year trading range for Celyad Oncology share price?
Celyad Oncology has traded in the range of 0.212 € to 1.22 € during the past year
What is the PE ratio of Celyad Oncology?
The price to earnings ratio of Celyad Oncology is -2.7
What is the cash to sales ratio of Celyad Oncology?
The cash to sales ratio of Celyad Oncology is 220
What is the reporting currency for Celyad Oncology?
Celyad Oncology reports financial results in EUR
What is the latest annual turnover for Celyad Oncology?
The latest annual turnover of Celyad Oncology is EUR 102k
What is the latest annual profit for Celyad Oncology?
The latest annual profit of Celyad Oncology is EUR -8.45M
What is the registered address of Celyad Oncology?
The registered address for Celyad Oncology is AXIS BUSINESS PARK, RUE ANDRE DUMONT 9, MONT-SAINT-GUIBERT, WALLOON BRABANT, 1435
What is the Celyad Oncology website address?
The website address for Celyad Oncology is www.celyad.com
Which industry sector does Celyad Oncology operate in?
Celyad Oncology operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MLFTIFrance Tourisme Immobilier
0.0325 €
(35.42%)
2.67k
PHXMPHAXIAM Therapeutics SA
0.731 €
(32.43%)
107.48k
ALALOAcheterLouerFR
0.0024 €
(26.32%)
124.41M
SOFTSoftimat sa
0.92 €
(24.32%)
1k
ALLOGLogic Instrument
1.86 €
(20.00%)
458.26k
MLPRXParx Materials NV
0.112 €
(-30.86%)
7.46k
VACBTPierre & Vacances
0.08 €
(-20.00%)
10.56k
HDPLes Hotels De Paris
1.11 €
(-19.57%)
3.55k
ALMASMastrad
0.0296 €
(-19.57%)
8.76M
ALINVInvibes advertising
1.18 €
(-16.31%)
44.21k
ALCYBCybergun
0.0002 €
(0.00%)
440.53M
ATOAtos SE
0.0042 €
(2.44%)
209.55M
ALVERVergnet
0.0009 €
(12.50%)
182M
ALALOAcheterLouerFR
0.0024 €
(26.32%)
124.41M
ALHPIHopium SA
0.002 €
(-9.09%)
84.28M

Discussion

View Full Feed
BEIJING BILL BEIJING BILL 41 seconds ago
$DMN https://finance.yahoo.com/news/damon-inc-announces-closing-upsized-000900296.html
DMN
Chachang1 Chachang1 1 minute ago
NEWS Video!!!
https://markets.financialcontent.com/1discountbrokerage/article/accwirecq-2025-3-27-rltrs-real-intelligence-ri-to-add-professional-quality-video-with-premium-accounts
RLTR
BullNBear52 BullNBear52 1 minute ago
Opening Day has arrived.

https://investorshub.advfn.com/uimage/uploads/2025/3/27/burjnScreenshot_2025-03-27_8.13.00_AM.png
Chachang1 Chachang1 1 minute ago
You can now pay for an account at RI. More capabilities coming together.
RLTR
georgie18 georgie18 1 minute ago
DRMA...$2.08...🥳... https://www.prnewswire.com/news-releases/breaking-dermatas-xyngari-phase-3-trial-topline-data-meets-all-primary-endpoints-302412922.html
DRMA
georgie18 georgie18 2 minutes ago
DRMA...$2.08...🥳... https://www.prnewswire.com/news-releases/breaking-dermatas-xyngari-phase-3-trial-topline-data-meets-all-primary-endpoints-302412922.html
DRMA
BullNBear52 BullNBear52 2 minutes ago
Opening Day has arrived.

https://investorshub.advfn.com/uimage/uploads/2025/3/27/burjnScreenshot_2025-03-27_8.13.00_AM.png
georgie18 georgie18 2 minutes ago
DRMA...$2.08...🥳... https://www.prnewswire.com/news-releases/breaking-dermatas-xyngari-phase-3-trial-topline-data-meets-all-primary-endpoints-302412922.html
DRMA
BEIJING BILL BEIJING BILL 2 minutes ago
Looking for followup $TMGI https://finance.yahoo.com/news/marquie-group-joins-forces-city-130000481.html
TMGI
LTListener LTListener 2 minutes ago
Well, if I recall several posted here when going EM and implied that they thought it was to isolate the players in the sandbox, avoid distractions, etc, etc. Maybe indeed that is what was desired. I think a bunch of shares were accumulated those last few weeks before going to EM. I am guessing ma
RSPI
Trooperstocks Trooperstocks 2 minutes ago
$NRXP Update: NRx Pharmaceuticals is focused on the high unmet need for lifesaving treatments for people with severe bipolar depression and PTSD in the presence of suicidality.
Follow our journey.
http://NRxPharma.com #ketamine #PTSD #bipolar #NRX100 #NRX101 $NRXP
NRXP
prototype_101 prototype_101 3 minutes ago
Yves Safecapital interview confirms what I have theorized and been posting here the whole time since the Business Strategy changed!!

Lebby was taking on a Herculean task in-house with a woefully understaffed Devices team trying to meet the demands of CUSTOM 4x200 PIC's (listen to Yves
LWLG
sab63090 sab63090 3 minutes ago
George, just read your post...that's correct and the bottomline when reading this is to look for the 500,000 shs exercised and the "D" which shows how many shares were sold to pay the taxes.....he is holding on to those!

Links without explanation are helpful but do NOT provide clarity
AVXL
Stock_Barber Stock_Barber 3 minutes ago
Did you forget to switch to your RickNagra login again?
Market is still closed, feels like Sunday again.
DBMM
uranium-pinto-beans uranium-pinto-beans 3 minutes ago
The IPO market is starting to defrost in 2025 after several years of sluggish activity. Lower inflation, interest rate cuts, and a return to dealmaking (like Google's $32B purchase of Wiz) are encouraging companies to return to the public markets. That's especially true in sectors like cybersecurity
NVDA PFE
makinezmoney makinezmoney 4 minutes ago
$SPY: DouchieBag Dingbat DongaldDrumpf Pinatas for SALE.............

Sales going thru the ROOF........... Gonna make so much money.

You can smash or burn them like Effigys if you want.

Whatever works for you..... Tarrifss gonna take this SPY sub 500 !!!!!
SPY
BEIJING BILL BEIJING BILL 4 minutes ago
$blth https://www.otcmarkets.com/stock/BLTH/news/story?e&id=3189116
BLTH
BullNBear52 BullNBear52 4 minutes ago
The good thing is the Yankees are no longer the evil empire of MLB. LA has assumed the throne.
k9uwa k9uwa 4 minutes ago
Shkreli the Felon will bail and end up a positive while the Lemmings will be the bagholders. Perhaps next time around they can find a permanent cage for Martin.Yesterday again a nice sized BUY for MOC. Earlier yesterday it only took around 20K shares to drive the price down. I did get a small bite.
AVXL
fung_derf fung_derf 4 minutes ago
You haven't learned a thing, have you? And you lost $22k here?

iamadog

Re: karmakaziXpert post# 77715

Tuesday, October 10, 2023 9:47:39 AM

Post#
77716
of 82910
I don’t trust what people post . I read IHUB to find p
SNPW
Opti Mist Opti Mist 4 minutes ago
2025-03-27 11:46:00 GMT DJ Vertical Aerospace Price Target Announced at $15.00/Share by D. Boral Capital

EVTL, (Trade) has been initiated by D. Boral Capital as a buy at 15.0.

Opti
EVTL
MrMike241 MrMike241 5 minutes ago
The MAGATs that I know will only watch Fox News. That is a problem. I cannot convince them to even look at facts that aren't aired on Fox. If you will only listen to news from one source and question nothing they say, you might be in a cult.

I see Trump dissent on the internet, but I
BlazingStocks BlazingStocks 5 minutes ago
$COEP News February 20, 2025
COEPTIS NexGenAI Affiliates Network & MarketLeverage Announce Strategic Partnership to Revolutionize AI-Powered Affiliate Marketinghttps://finance.yahoo.com/news/coeptis-nexgenai-affiliates-network-marketleverage-122700809.html
COEP

Your Recent History

EU
CYAD
Celyad Oncology
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads